I think there is some "what could be" fatigue here. We may see a little bounce when the merger happens but no real support until an actual earnings report. The big run to .10 was caused by the MJ craze that was going on in the market. I do not expect it to be back to those levels anytime soon IMO. Once the merger takes place the diluted shares will neutralize the market response to the deal. Doc's will keep the company afloat while Pilus is developing and they search for more acquisitions which will enhance the company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.